Target Price | $15.30 |
Price | $11.32 |
Potential |
35.16%
register free of charge
|
Number of Estimates | 7 |
7 Analysts have issued a price target Sotera Health Co 2026 .
The average Sotera Health Co target price is $15.30.
This is
35.16%
register free of charge
$17.85
57.69%
register free of charge
$13.13
15.99%
register free of charge
|
|
A rating was issued by 12 analysts: 8 Analysts recommend Sotera Health Co to buy, 4 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Sotera Health Co stock has an average upside potential 2026 of
35.16%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 1.10 | 1.15 |
4.87% | 4.78% | |
EBITDA Margin | 32.68% | 50.25% |
0.72% | 53.74% | |
Net Margin | 4.03% | 18.60% |
17.25% | 361.62% |
8 Analysts have issued a sales forecast Sotera Health Co 2025 . The average Sotera Health Co sales estimate is
This results in the following potential growth metrics:
9 Analysts have issued an Sotera Health Co EBITDA forecast 2025. The average Sotera Health Co EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
8 Sotera Health Co Analysts have issued a net profit forecast 2025. The average Sotera Health Co net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 0.16 | 0.76 |
11.11% | 375.00% | |
P/E | 14.98 | |
EV/Sales | 4.53 |
8 Analysts have issued a Sotera Health Co forecast for earnings per share. The average Sotera Health Co EPS is
This results in the following potential growth metrics and future valuations:
Sotera Health Co...
Analyst | Rating | Action | Date |
---|---|---|---|
Barclays |
Locked
➜
Locked
|
Locked | Jun 24 2025 |
Goldman Sachs |
Locked
➜
Locked
|
Locked | May 05 2025 |
Piper Sandler |
Locked
➜
Locked
|
Locked | Apr 23 2025 |
Barclays |
Locked
➜
Locked
|
Locked | Apr 10 2025 |
Barclays |
Locked
➜
Locked
|
Locked | Feb 28 2025 |
Barclays |
Locked
➜
Locked
|
Locked | Feb 18 2025 |
RBC Capital |
Locked
➜
Locked
|
Locked | Nov 21 2024 |
Analyst Rating | Date |
---|---|
Locked
Barclays:
Locked
➜
Locked
|
Jun 24 2025 |
Locked
Goldman Sachs:
Locked
➜
Locked
|
May 05 2025 |
Locked
Piper Sandler:
Locked
➜
Locked
|
Apr 23 2025 |
Locked
Barclays:
Locked
➜
Locked
|
Apr 10 2025 |
Locked
Barclays:
Locked
➜
Locked
|
Feb 28 2025 |
Locked
Barclays:
Locked
➜
Locked
|
Feb 18 2025 |
Locked
RBC Capital:
Locked
➜
Locked
|
Nov 21 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.